Enliven Therapeutics to Present at Upcoming Investor Conferences

Company Overview - Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics aimed at improving both longevity and quality of life [3] - The company employs a precision oncology approach to address existing and emerging unmet medical needs, enhancing survival and overall well-being [3] - Enliven's discovery process integrates insights from clinically validated biological targets with differentiated chemistry to create potentially first-in-class or best-in-class therapies [3] Upcoming Events - Enliven will present at the TD Cowen's 6th Annual Oncology Innovation Summit on May 27, 2025, at 1:00 p.m. ET in a fireside chat format [1] - The company will also participate in the Jefferies Global Healthcare Conference on June 4, 2025, at 4:20 p.m. ET, again in a fireside chat format [1] - Additionally, Enliven is scheduled to present at the Goldman Sachs Annual Global Healthcare Conference on June 10, 2025, at 4:00 p.m. ET [2] - All fireside chats will be webcast live and archived for 90 days on the company's investor relations website [2]